PCVX · NASDAQ · STOCK
Vaxcyte, Inc.
$59.22
52W $29.81 – $65.00
66/100
$8.55B
-7.8
1.21
Is PCVX Bullish or Bearish?
Mixed.
Innellis AI committee rates Vaxcyte, Inc. (PCVX) Insufficient Data with a composite score of 66/100
, based on 3 analysts with 67% agreement.
Last updated August 11, 2026.
What Would Change This View
No threshold can be published for PCVX. The committee has not produced a scored recommendation, so there is no line for it to cross. Innellis does not infer one.
Executive Summary
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
66/100
Agreement
67%
Analysts
3
Conviction
Low Data
Sector Rank
Top 12%
of 192 Healthcare peers
Technical Analyst
bullish
63
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− Price structure (LH_LL) contradicts the uptrend -- mixed signals
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
65.6
Neutral
MACD Histogram
0.341
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$52.90
Resistance
$61.70
Bollinger %B
0.95
Inside Bands
Price vs Moving Averages
EMA 9
$57.16
Above
EMA 21
$56.29
Above
EMA 50
$55.28
Above
EMA 200
$52.99
Above
Fundamental Analysis
Valuation
92
Profitability
0
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio
-7.8×
P/B Ratio
3.10×
PEG Ratio
0.15
Dividend Yield
0.00%
52W High
$65.00
52W Low
$29.81
Quality & Growth
ROE
-2854.7%
ROA
-2516.9%
Gross Margin
0.0%
Operating Margin
0.0%
Revenue Growth YoY
—
Debt / Equity
0.04
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -7.8 (inexpensive relative to a 15-40x range); Price-to-book of 3.1x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -28.5%; Return on assets of -25.2%; Net margin of 0.0%; Gross margin of 0.0%; Current ratio of 5.72 (healthy short-term liquidity); Debt-to-equity of 0.04; Free cash flow per share is negative (-8.32); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full PCVX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →